Genotypic resistance testing improves antiretroviral treatment outcomes in a cohort of adolescents in Cameroon: Implications in the dolutegravir-era

Acquired drug resistance (ADR) is common among adolescents living with perinatal HIV (APHI) in sub-Saharan Africa (SSA). Personalized management has the potential to improve pediatric antiretroviral therapy (ART), even in the presence of long-term treatment and HIV-1 subtype diversity. We sought to...

Descripción completa

Detalles Bibliográficos
Autores principales: PABO, WILLY LE ROI TOGNA, NJUME, DEBIMEH, NDIP, ROLAND NDIP, TAKOU, DÉSIRÉ, SANTORO, MARIA-MERCEDES, CHENWI, COLLINS, BELOUMOU, GRACE, SEMENGUE, EZECHIEL NGOUFACK JAGNI, NKA, ALEX DURAND, KA'E, AUDE CHRISTELLE, TETO, GEORGES, DAMBAYA, BEATRICE, DJUPSA, SANDRINE, NYASA, RAYMOND BABILA, ANGUECHIA, DAVY HYACINTHE GOUISSI, KAMTA, CEDRIC, BALA, LIONEL, LAMBO, VIRGINIE, SOSSO, SAMUEL MARTIN, COLIZZI, VITTORIO, PERNO, CARLO FEDERICO, FOKAM, JOSEPH, NDJOLO, ALEXIS
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658463/
https://www.ncbi.nlm.nih.gov/pubmed/38020274
http://dx.doi.org/10.4081/jphia.2023.2612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658463/
https://www.ncbi.nlm.nih.gov/pubmed/38020274
http://dx.doi.org/10.4081/jphia.2023.2612

Ejemplares similares